Section of Orthopaedic Surgery, Department of Surgery, University of Calgary, Calgary, Alberta, Canada.
McCaig Institute for Bone and Joint Health, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Cartilage. 2021 Jan;12(1):31-41. doi: 10.1177/1947603518812557. Epub 2018 Nov 22.
Osteochondral allograft transplantation is a procedure to treat focal osteochondral lesions (OCLs), but is limited by tissue availability, the quality of transplanted tissue, and inconsistent storage protocols. The objective of this study was to assess the clinical outcomes of a novel tissue procurement, storage, and quality control protocol in treating OCLs.
Prospective case series. Donor cadaveric tissue was processed, stored, and the tissue quality analyzed using the unique tissue preservation protocol developed at our institution. Advanced cross-sectional imaging was used to size match donor tissue with recipient patients. Osteochondral allografts were transplanted using the Arthrex Allograft OATS. Patients were evaluated with the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Knee injury and Osteoarthritis Outcome Score (KOOS), visual analog scale (VAS), and 36-Item Short Form Survey (SF-36) preoperatively and at 1 year and 2 years postoperatively.
Twenty patients (17 knees, 3 shoulders) were included in the study. There was a significant improvement in the following scores: overall WOMAC score, WOMAC function and pain subcategories; KOOS pain, knee-related symptoms, activities of daily living, sports and recreation, and quality of life; SF-36 physical functioning, physical role, pain, and social functioning subcategories; and VAS at all time points postoperatively. There was a significant improvement in WOMAC stiffness at 2 years postoperatively. There were 2 failures, defined by graft subsidence and persistent pain requiring reoperation.
The protocol developed at our institution for OAT resulted in significant clinical improvement in patients with OCLs and is an improvement on existing tissue storage techniques.
骨软骨同种异体移植是一种治疗局灶性骨软骨病变(OCL)的方法,但受到组织可用性、移植组织质量和不一致的储存方案的限制。本研究的目的是评估一种新的组织获取、储存和质量控制方案在治疗 OCL 中的临床效果。
前瞻性病例系列研究。供体尸体组织经过处理、储存,并使用我们机构开发的独特组织保存方案进行组织质量分析。先进的横断面成像用于对供体组织与受者患者进行大小匹配。使用 Arthrex 同种异体 OATS 移植骨软骨同种异体移植物。患者在术前、术后 1 年和 2 年分别用 Western Ontario 和 McMaster 大学骨关节炎指数(WOMAC)、膝关节损伤和骨关节炎结果评分(KOOS)、视觉模拟量表(VAS)和 36 项简短健康调查(SF-36)进行评估。
本研究纳入了 20 名患者(17 个膝关节,3 个肩关节)。以下评分均有显著改善:总体 WOMAC 评分、WOMAC 功能和疼痛亚组;KOOS 疼痛、膝关节相关症状、日常生活活动、运动和娱乐、生活质量;SF-36 生理功能、生理角色、疼痛和社会功能亚组;以及术后所有时间点的 VAS。术后 2 年 WOMAC 僵硬评分显著改善。有 2 例失败,定义为移植物下沉和持续疼痛需要再次手术。
我们机构开发的 OAT 方案可显著改善 OCL 患者的临床疗效,优于现有的组织储存技术。